Browse > Article
http://dx.doi.org/10.22246/jikm.2022.43.2.229

A Case Report on Opioid-Induced Constipation in a Patient with Cancer Treated by Jowiseunggi-tang  

Yoon, Jee-Hyun (Dept of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong)
Park, Su Bin (Dept of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong)
Kim, Eun Hye (Dept of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong)
Lee, Jee Young (Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation)
Yoon, Seong Woo (Dept of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong)
Publication Information
The Journal of Internal Korean Medicine / v.43, no.2, 2022 , pp. 229-236 More about this Journal
Abstract
Objective: Jowiseunggi-tang (JWSGT) is a traditional herbal medicine commonly used for purgative activity in constipation. This study evaluates JWSGT for the treatment of opioid-induced constipation (OIC), the most common and debilitating gastrointestinal effect of opioid use. Methods: A 64-year-old man with floor of mouth cancer was hospitalized for OIC, and JWSGT was administered orally twice a day for 10 days, along with acupuncture, moxibustion, and cupping. The primary outcome measures were defecation type according to the Bristol Stool Form Scale (BSFS) and the frequency of bowel movements. The Brief Fatigue Inventory (BFI) and the Functional Assessment of Cancer Therapy-General (FACT-G) were used as secondary measures. Results: After three days of JWSGT administration, spontaneous bowel movements were observed two to three times per week with improved BSFS from type 2 to 4. A reduction in BFI score (8.7 to 2.0) and an increase in FACT-G score (44.3 to 59.0) suggested an improvement in fatigue level and quality of life. Conclusion: This is the first report to assess the efficacy of JWSGT for the management of OIC in patients with cancer, and JWSGT may be an effective option to improve symptoms and quality of life in this group.
Keywords
opioid-induced constipation; Jowiseunggi-tang; cancer; Korean medicine; quality of life;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2009;10(1):35-42.   DOI
2 Lee BJ, Kim DH, Kim SH. Study on Seunggitangryu (承氣湯類) of Sanghannon(傷寒論). Journal of Haehwa Medicine 1991;8(1):205-21.
3 Zhang FL, Lin HS, He QY. Effect of electroacupuncture in treating morphine sulfate caused constipation in tumor patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009;29(10):922-5.
4 Koppen IJN, Velasco-Benitez CA, Benninga MA, Di Lorenzo C, Saps M. Using the Bristol Stool Scale and Parental Report of Stool Consistency as Part of the Rome III Criteria for Functional Constipation in Infants and Toddlers. J Pediatr 2016;177:44-8.   DOI
5 Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, et al. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage 2005;29(2):165-72.   DOI
6 Sohn Y, Kang HC, Kim KS, Park SM, Sohn NW, Jung HS, et al. Protective effects of natrii sulfas on cerebral focal ischemia induced by MCAO in rats. Am J Chin Med 2009;37(2):273-93.   DOI
7 Zhu HD, Gong Z, Hu BW, Wei QL, Kong J, Peng CB. The efficacy and safety of transcutaneous acupoint interferential current stimulation for cancer pain patients with opioid-induced constipation: A prospective randomized controlled study. Integr Cancer Ther 2018;17(2):437-43.   DOI
8 Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007;61(7):1181-7.   DOI
9 Candrilli SD, Davis KL, Iyer S. Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy. J Pain Palliat Care Pharmacother 2009;23(3):231-41.   DOI
10 Boland JW, Boland, EG. Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ 2017;358:J3313.   DOI
11 Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11(3):570-9.   DOI
12 Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil 2014;26(10):1386-95.   DOI
13 Cao YJ, Pu ZJ, Tang YP, Shen J, Chen YY, Kang A, et al. Advances in bio-active constituents, pharmacology and clinical applications of rhubarb. Chin Med. 2017;12:36.   DOI
14 Committee of Digestive Diseases, National Korean Medicine College. Gastroenterology. 1st edition. Seoul: Koonja publisher; 2008, p. 189-96, 523.
15 Chen CM, Lin LZ, Zhang EX. Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin J Integr Med 2014;20(7):496-502.   DOI
16 Yoon JH, Kim EH, Lee JY, Yoon SW. A Literature Review of Management for Opioid-Induced Constipation in Cancer Patients. J of Kor Traditional Oncology 2020;25(2):37-49.   DOI
17 van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag 2016;51(6):1070-90.e9.   DOI
18 World Health Organization. WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Available from: URL: https://www.who.int/publications/i/item/9789241550390.
19 Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 2017;92(4):372-81.   DOI
20 Abramowitz L, Beziaud N, Labreze L, Giardina V, Causse C, Chuberre B, et al. Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study. J Med Econ 2013;16(12):1423-33.   DOI
21 Kumar L, Barker C, Emmanuel A. Opioidinduced constipation: pathophysiology, clinical consequences, and management. Gastroenterol Res Pract 2014;2014:141737.   DOI
22 Ahmedzai SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid 2010;2010:2407.
23 Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotte F, et al. ESMO Guidelines Committee. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29(Suppl 4):iv111-25.   DOI